Effects of a peripheral α adrenergic-receptor antagonist on the hemodynamic changes induced by medetomidine administration in conscious dogs

American Journal of Veterinary Research

Volumn 69, Issue 6, 2008, Pages 728-736

  Enouri, Saad S ^a   Kerr, Carolyn L ^a   McDonnell, Wayne N ^a   O'Sullivan, M Lynne ^a   Teixeira Neto, Francisco J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCOPYRRONIUM BROMIDE; MEDETOMIDINE; N [2 (1,3,4,6,7,12B HEXAHYDRO 2' OXOSPIRO[2H BENZOFURO[2,3 A]QUINOLIZINE 2,4' IMIDAZOLIDIN] 3' YL)ETHYL]METHANESULFONAMIDE; SODIUM CHLORIDE; ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; QUINOLIZINE DERIVATIVE;

ARTICLE; BLOOD GAS ANALYSIS; BLOOD SAMPLING; CARDIOPULMONARY HEMODYNAMICS; CARDIOPULMONARY INSUFFICIENCY; CENTRAL VENOUS PRESSURE; CONSCIOUSNESS; CONTROLLED STUDY; DOG; DRUG EFFECT; HEART INDEX; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TENSION; RANDOMIZATION; SEDATION; SYSTEMIC VASCULAR RESISTANCE; VASOCONSTRICTION; ANIMAL; BLOOD PRESSURE; BREATHING; CROSSOVER PROCEDURE; DRUG INTERACTION; HEART OUTPUT; PHYSIOLOGY; VASCULAR RESISTANCE;

ANIMALIA; CANIS FAMILIARIS;

ADRENERGIC ANTAGONISTS; ANALGESICS, NON-NARCOTIC; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CROSS-OVER STUDIES; DOGS; DRUG INTERACTIONS; GLYCOPYRROLATE; HEART RATE; MALE; MEDETOMIDINE; MUSCARINIC ANTAGONISTS; QUINOLIZINES; RANDOM ALLOCATION; RESPIRATION; VASCULAR RESISTANCE;

EID: 45949110911     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.6.728     Document Type: Article

References (40)

1. Vaha-Vahe T. Clinical evaluation of medetomidine, a novel sedative and analgesic drug for dogs and cats. Acta Vet Scand 1989;30:267-273.
2. Vainio O, Vaha-Vahe T, Palmu L. Sedative and analgesic effects of medetomidine in dogs. J Vet Pharmacol Ther 1989; 12:225-231.
3. Pypendop BH, Verstegen JP. Hemodynamic effects of medetomidine in the dog: a dose titration study. Vet Surg 1998;27:612-622.
4. Clarke KW, England GCW. Medetomidine, a new sedative-analgesic for use in the dog and its reversal with atipamezole. J Small Anim Pract 1989;30:343-348.
5. Savola JM. Cardiovascular actions of medetomidine and their reversal by atipamezole. Acta Vet Scand Suppl 1989;85:39-47.
6. Vainio O, Palmu L. Cardiovascular and respiratory effects of medetomidine in dogs and influence of anticholinergics. Acta Vet Scand 1989;30:401-408.
7. Vickery RG, Maze M. Action of the stereoisomers of medetomidine, in halothane-anesthetized dogs. Acta Vet Scand Suppl 1989;85:71-76.
8. Pypendop B, Verstegen J. Cardiorespiratory effects of a combination of medetomidine, midazolam, and butorphanol in dogs. Am J Vet Res 1999;60:1148-1154.
9. Kuo WC, Keegan RD. Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol in dogs. Am J Vet Res 2004;65:931-937.
10. Kuusela E, Raekallio M, Anttila M, et al. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J Vet Pharmacol Ther 2000;23:15-20.
11. Hayashi K, Nishimura R, Yamaki A, et al. Cardiopulmonary effects of medetomidine, medetomidine-midazolam and medetomidine-midazolam-atipamezole in dogs. J Vet Med Sci 1995;57:99-104.
12. Dodam JR, Cohn LA, Durham HE, et al. Cardiopulmonary effects of medetomidine, oxymorphone, or butorphanol in selegiline-treated dogs. Vet Anaesth Analg 2004;31:129-137.
13. England GC, Clarke KW. The use of medetomidine/fentanyl combinations in dogs. Acta Vet Scand Suppl 1989;85:179-186.
14. Ko JC, Weil AB, Kitao T, et al. Oxygenation in medetomidine-sedated dogs with and without 100% oxygen insufflation. Vet Ther 2007;8:51-60.
15. Pypendop B, Serteyn D, Verstegen J. Hemodynamic effects of medetomidine-midazolam-butorphanol and medetomidine-midazolam-buprenorphine combinations and reversibility by atipamezole in dogs. Am J Vet Res 1996;57:724-730.
16. Dyson DH, Maxie MG, Schnurr D. Morbidity and mortality associated with anesthetic management in small animal veterinary practice in Ontario. J Am Anim Hosp Assoc 1998;34:325-335.
17. Clarke KW, Hall LW. A survey of anaesthesia in small animal practice: AVA/BSAVA report. J Assoc Vet Anaesth 1990; 17:4-10.
18. Scheinin H, Virtanen R, MacDonald E, et al. Medetomidine - a novel alpha 2-adrenoceptor agonist: a review of its pharmacodynamic effects. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:635-651.
19. Bloor BC, Frankland M, Alper G, et al. Hemodynamic and sedative effects of dexmedetomidine in dog. J Pharmacol Exp Ther 1992;263:690-697.
20. Sinclair MD, McDonell WN, O'Grady M, et al. The cardiopulmonary effects of romifidine in dogs with and without prior or concurrent administration of glycopyrrolate. Vet Anaesth Analg 2002;29:1-13.
21. Housmans PR. Effects of dexmedetomidine on contractility, relaxation, and intracellular calcium transients of isolated ventricular myocardium. Anesthesiology 1990;73:919-922.
22. Flacke WE, Flacke JW, Blow KD, et al. Effect of dexmedetomidine, an alpha 2-adrenergic agonist, in the isolated heart. J Cardiothorac Vasc Anesth 1992;6:418-423.
23. Day TK, Muir WW III. Alpha 2-adrenergic receptor agonist effects on supraventricular and ventricular automaticity in dogs with complete atrioventricular block. Am J Vet Res 1993;54:136-141.
24. de Morais HS, Muir WW III. The effects of medetomidine on cardiac contractility in autonomically blocked dogs. Vet Surg 1995;24:356-364.
25. Pagel PS, Proctor LT, Devcic A, et al. A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs. J Cardiothorac Vasc Anesth 1998;12:429-434.
26. Short CE. Effects of anticholinergic treatment on the cardiac and respiratory systems in dogs sedated with medetomidine. Vet Rec 1991;129:310-313.
27. Ko JC, Fox SM, Mandsager RE. Effects of preemptive atropine administration on incidence of medetomidine-induced bradycardia in dogs. J Am Vet Med Assoc 2001;218:52-58.
28. Alibhai HI, Clarke KW, Lee YH, et al. Cardiopulmonary effects of combinations of medetomidine hydrochloride and atropine sulphate in dogs. Vet Rec 1996;138:11-13.
29. Bryant CE, Thompson J, Clarke KW. Characterisation of the cardiovascular pharmacology of medetomidine in the horse and sheep. Res Vet Sci 1998;65:149-154.
30. Clineschmidt BV, Pettibone DJ, Lotti VJ, et al. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066. J Pharmacol Exp Ther 1988;245:32-40.
31. Allen DG, Nymeyer D. A preliminary investigation on the use of thermodilution and echocardiography as an assessment of cardiac function in the cat. Can J Comp Med 1983;47:112-117.
32. Boyd CJ, McDonell WN, Valliant A. Comparative hemodynamic effects of halothane and halothane-acepromazine at equipotent doses in dogs. Can J Vet Res 1991;55:107-112.
33. Haskins S, Pascoe PJ, Ilkiw JE, et al. Reference cardiopulmonary values in normal dogs. Comp Med 2005;55:156-161.
34. Szemeredi K, Stull R, Kopin IJ, et al. Effects of a peripherally acting alpha 2-adrenoceptor antagonist (L-659,066) on hemodynamics and plasma levels of catechols in conscious rats. Eur J Pharmacol 1989;170:53-59.
35. Schafers RF, Elliott HL, Howie CA, et al. A preliminary, clinical pharmacological assessment of L-659,066, a novel alpha 2-adrenoceptor antagonist. Br J Clin Pharmacol 1992;34:521-526.
36. Flacke WE, Flacke JW, Bloor BC, et al. Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog. J Cardiothorac Vasc Anesth 1993;7:41-49.
37. Pettifer GR, Dyson DH. Comparison of medetomidine and fentanyl-droperidol in dogs: sedation, analgesia, arterial blood gases and lactate levels. Can J Vet Res 1993;57:99-105.
38. Bloor BC, Abdul-Rasool I, Temp, J, et al. The effects of medetomidine, an alpha 2-adrenergic agonist, on ventilatory drive in the dog. Acta Vet Scand Suppl 1989;85:65-70.
39. Ko JC, Fox SM, Mandsager RE. Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs. J Am Vet Med Assoc 2000;216:1578-1583.
40. Vainic, O. Reversal of medetomidine-induced cardiovascular and respiratory changes with atipamezole in dogs. Vet Rec 1990;127:447-450.